NSAIDs API Market: By Molecule Type (Ibuprofen, Aspirin, Paracetmol, Diclofenac, and Others), By Formulation (Tablets, Capsules. Suspension, Topical Presentations, and Others), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

NSAIDs API Market size was valued at USD x billion in 2021 and is expected to grow at a CAGR of x% from 2022-2028.owing to increase in prevalence of arthritis, which is the major cause for the disability and growing number of geriatric population across the globe drives the growth of the market. For instance, According to Center for Disease Control and Prevention (CDC), from 2013-2015, approximately 54.4 Mn US adults had some form of arthritis such as gout, rheumatoid arthritis treatment, fibromyalgia, and lupus and estimated to reach 78 Mn adults aged 18 years older are projected to have arthritis by 2040.  NSAIDs are drug class that groups together drugs that provide analgesic and anti-pyretic effects. Moreover, increasing access to healthcare with the rapid penetration of technology and other developments in the healthcare sector has increased the consumption of drugs, thereby directly creating positive impact on NSAID market.  However, availability of alternative products in the market for NSAIDs and development of advanced medications are expected to hamper the growth of the market. This report studies Global NSAIDs API market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Global NSAIDs API market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the Global NSAIDs API market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in Global NSAIDs API.

Global Nsaids Api Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific

Low cost of the non-steroidal anti-inflammatory drugs such as ibuprofen, diclofenac, piroxicam, aspirin, and other drugs coupled with the better availability of the products boost the revenue growth of global NSAIDs market over the forecast years. Formulation of NSAIDs for the patient convenience also enhance the market revenue in the forthcoming years. For instance, Pfizer, Inc. marketing the Flector (Diclofenac Epolamine Topical Patch) to treat acute pain due to minor strains, sprains, and bruises. In addition, NSAIDs also available in the injectable forms which are easy to administer the patients unable to swallow the tablets. Moreover, Mylan laboratories manufacturing Brufen effervescent granules that can be easily administered for the geriatric and paediatric patients

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Nsaids Api Market Segmentation

Molecule Type
  • Ibuprofen
  • Aspirin
  • Paracetmol
  • Diclofenac
  • Others
  • Tablets
  • Capsules
  • Suspension
  • Topical Presentations
  • Others
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Granules India Ltd. (India)
  • Xinuha Pharm (China)
  • IOL Chemicals and Pharmaceuticals Ld. (India)
  • Strides Pharma Science Limited (India)
  • SI Group (U.S.)
  • BASF SE (Germany)
  • Bayer AG (Germany)
  • Pfizer, Inc. (U.S.)